Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Pamidronate and Calcium Supplement

Research Papers that Mention the Interaction

CA 125 tended to be lower in the long-term PD patients and also in APD patients, but statistical significance was missing.
Kidney and Blood Pressure Research  •  2003  |  View Paper
These results suggest that forearm bone loss after intravenous pamidronate treatment for moderate-to-severe Paget's disease can largely be prevented by administration of calcium and calcitriol.
Bone  •  1999  |  View Paper
Oral pamidronate caused a dose-related reduction on the biochemical markers of bone resorption, i.e. fasting urinary calcium , hydroxyproline, pyridinoline and deoxypyridinoline that was seen already after the first week.
Upsala journal of medical sciences  •  1991  |  View Paper
All patients responded to APD with a rapid decrease of plasma calcium concentration from 3.44 +/- 0.10 mmol/l at day 0 to 2.33 +/- 0.06 at day 6, p less than 0.001).
Schweizerische medizinische Wochenschrift  •  1988  |  View Paper
(3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (… calcium (1 g/day) with that of calcium alone on the bone mass of patients receiving long-term glucocorticoid therapy, the mean ….2% between 0 and 6 months (p less than 0.06) and then remained stable between 6 and 12 months.
The Lancet  •  1988  |  View Paper
He was noted to have persistently high calcium , which required multiple doses of pamidronate.
BMJ case reports  •  2021  |  View Paper
In terms of percentage BMD change at the femoral neck, both pamidronate and ibandronate combined with calcium demonstrated a remarkable gain compared with calcium (MD, 7.02; 95% CrI, 0.30–13.29 and MD, 7.30; 95% CrI, 0.32–14.22, respectively).
Chinese medical journal  •  2018  |  View Paper
Despite pamidronate treatment , the calcium level continued to rise.
Journal of pediatric hematology/oncology  •  2016  |  View Paper
Since pamidronate reduces mineral resorption from tissues, calcium and phosphate replacements increase systemic mineral deposits.
Pediatric blood & cancer  •  2008  |  View Paper
In the presence of calcium, pamidronate and alendronate were toxic to the cells, with pamidronate being more toxic than alendronate.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research  •  1999  |  View Paper
Show More